|This Slide: #17 of 100|
Slide #17. Prestige Brands Holdings, Inc. — Hydralyte
Prestige Brands Holdings, Inc. (NYSE:PBH)
Prestige Brands Holdings, Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of Hydralyte from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading over-the-counter oral rehydration brand in Australia, and will be marketed and sold through Care Pharmaceuticals ("Care"), Prestige's subsidiary in Australia.
Prestige Consumer Healthcare is a holding company. Through its subsidiaries, Co. develops, manufactures, markets, sells and distributes over-the-counter (OTC) healthcare products to mass merchandisers and drug, food, dollar, convenience, club and e-commerce stores in North America and in Australia and certain other international markets. Co.'s portfolio of OTC Healthcare products includes, among others, Clear Eyes eye and ear care products, Compound W wart removal, Chloraseptic sore throat liquids and lozenges, DenTek oral care products, Luden's cough drops, Monistat women's health products, Nix lice and parasite treatment products and Fess Nasal Saline Sprays and Washes.
PBH SEC Filing Email Alerts Service
Open the PBH Page at The Online Investor »
Hold (2.50 out of 4)